agitation phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (13)
Papers in which this entity is mentioned.
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
- Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. (2011)
- Classification of neurocognitive disorders in DSM-5: a work in progress. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Genome-wide scan for self-rating of the effects of alcohol in American Indians. (2010)
- The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. (2010)
- Fetal effects of psychoactive drugs. (2009)
- Antagonists of alcohol inhibition of cell adhesion. (2000)
- Impairments of brain and behavior: the neurological effects of alcohol. (1997)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| agitation | phenotype | 13 | 15 |
| agitated | phenotype | — | — |